查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1778495

全球鳳梨蛋白酶市場：成長、規模及趨勢分析 - 按形態與應用 - 至2034年的區域展望、競爭策略及細分市場預測

Bromelain Market Size- By Form, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

根據《全球鳳梨蛋白酶市場：成長、規模和趨勢分析 - 依形式、依應用 - 區域展望、競爭策略和2034年細分預測》報告，全球鳳梨蛋白酶市場規模預計到2034年將達到 5,624萬美元，年複合成長率為 6.94%。

鳳梨蛋白酶是一種天然酶，存在於鳳梨莖和果實中。它有助於分解蛋白質，有利於肉類嫩化、消化和消炎。由於其藥用和功能特性，鳳梨蛋白酶廣泛應用於補充劑、製藥、化妝品以及食品和飲料行業。

限制因素：儘管鳳梨蛋白酶的用途日益廣泛，但其市場仍面臨許多挑戰。鳳梨蛋白酶提取自鳳梨，而鳳梨受季節和環境因素的影響，導致供應和價格不穩定。此外，鳳梨蛋白酶的萃取和精製過程耗時長、成本高，限制了中小企業的生產擴充性。

調查範圍

報告指標詳情

市場規模：2021-2034年

基準年：2024年

預測期：2025-2034年

目標細分市場：依類型和用途

涵蓋地區：北美、拉丁美洲、亞太地區、歐洲、中東和非洲

目標公司：Advanced Enzymes、Biozyme Laboratories、Creative Enzymes、Digestive Enzymes International、Enzybel International、Enzyme Development、Hong Mao Biochemicals、Integrative Therapeutics、Mountain Fresh、Nanning Doing-Higher Bio-Tech、Nanning Pangbo Biological Engineering

全球鳳梨蛋白酶市場細分：

依形式：全球鳳梨蛋白酶市場依形式分為粉末、液體和其他。

依應用：全球鳳梨蛋白酶市場依應用分為食品和飲料、膳食補充劑、藥品、化妝品和個人護理等。

依地區：研究還包括來自北美、拉丁美洲、亞太地區、歐洲以及中東和非洲的資料。

目錄

第1章 引言

第2章 調查方法

第3章 執行摘要

第4章 市場動態

  • 促進因素、限制因素、機會與挑戰分析

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭態勢

  • 全球鳳梨蛋白酶市場：製造地分佈、銷售區域與產品類型
  • 全球鳳梨蛋白酶市場的併購、合作夥伴關係、產品發布和合作

第7章 全球鳳梨蛋白酶市場，依形式（百萬美元），2021-2034年

  • 粉末
  • 液體
  • 其他

第8章 全球鳳梨蛋白酶市場，依應用（百萬美元），2021年至2034年

  • 食品/飲料
  • 營養補充品
  • 製藥
  • 化妝品和個人護理
  • 其他

第9章 2021-2034年全球鳳梨蛋白酶市場（百萬美元）

  • 全球鳳梨蛋白酶市場規模和市場佔有率

第10章 2021年至2034年全球鳳梨蛋白酶市場，依地區（百萬美元）

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他

第11章 公司簡介

  • Advanced Enzymes
  • Biozyme Laboratories
  • Creative Enzymes
  • Digestive Enzymes International
  • Enzyme Development
  • Hong Mao Biochemicals
  • Integrative Therapeutics
  • Mountain Fresh
  • Nanning Doing-Higher Bio-Tech
  • 其他

第12章 結論

第13章 簡稱表

第14章 參考鏈接

簡介目錄
Product Code: FOOD2576

Bromelain Market Introduction and Overview

According to SPER Market Research, 'Global Bromelain Market Size- By Form, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034' the Global Bromelain Market is estimated to reach USD 56.24 million by 2034 with a CAGR of 6.94%.

Bromelain is a naturally occurring enzyme found in pineapple stems and fruits. It aids in protein breakdown, making it effective for purposes such as meat tenderisation, digestive support, and inflammation reduction. Because of its medicinal and functional properties, bromelain is widely utilised in supplements, pharmaceuticals, cosmetic products, and the food and beverage industry.

Restraints: Despite its growing use, the bromelain market faces several challenges. The primary issue is that bromelain is sourced from pineapples, which are affected by seasonal and environmental factors, leading to unstable supply and pricing. The process of extracting and purifying bromelain is also time-consuming and expensive, limiting production scalability for smaller companies.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Form, By Application

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Advanced Enzymes, Biozyme Laboratories, Creative Enzymes, Digestive Enzymes International, Enzybel International, Enzyme Development, Hong Mao Biochemicals, Integrative Therapeutics, Mountain Fresh, Nanning Doing-Higher Bio-Tech, Nanning Pangbo Biological Engineering.

Global Bromelain Market Segmentation:

By Form: Based on the Form, Global Bromelain Market is segmented as; Powder, Liquid, Others

By Application: Based on the Application, Global Bromelain Market is segmented as; Food & beverages, Nutraceuticals, Pharmaceuticals, Cosmetics & personal care, Others

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bromelain Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bromelain Market

7. Global Bromelain Market, By Form (USD Million) 2021-2034

  • 7.1. Powder
  • 7.2. Liquid
  • 7.3. Others

8. Global Bromelain Market, By Application (USD Million) 2021-2034

  • 8.1. Food & beverages
  • 8.2. Nutraceuticals
  • 8.3. Pharmaceuticals
  • 8.4. Cosmetics & personal care
  • 8.5. Others

9. Global Bromelain Market, (USD Million) 2021-2034

  • 9.1. Global Bromelain Market Size and Market Share

10. Global Bromelain Market, By Region, (USD Million) 2021-2034

  • 10.1. Asia-Pacific
    • 10.1.1. Australia
    • 10.1.2. China
    • 10.1.3. India
    • 10.1.4. Japan
    • 10.1.5. South Korea
    • 10.1.6. Rest of Asia-Pacific
  • 10.2. Europe
    • 10.2.1. France
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Spain
    • 10.2.5. United Kingdom
    • 10.2.6. Rest of Europe
  • 10.3. Middle East and Africa
    • 10.3.1. Kingdom of Saudi Arabia
    • 10.3.2. United Arab Emirates
    • 10.3.3. Qatar
    • 10.3.4. South Africa
    • 10.3.5. Egypt
    • 10.3.6. Morocco
    • 10.3.7. Nigeria
    • 10.3.8. Rest of Middle-East and Africa
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. Mexico
    • 10.4.3. United States
  • 10.5. Latin America
    • 10.5.1. Argentina
    • 10.5.2. Brazil
    • 10.5.3. Rest of Latin America

11. Company Profile

  • 11.1. Advanced Enzymes
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Biozyme Laboratories
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Creative Enzymes
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Digestive Enzymes International
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Enzyme Development
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Hong Mao Biochemicals
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Integrative Therapeutics
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Mountain Fresh
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Nanning Doing-Higher Bio-Tech
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links